These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

810 related articles for article (PubMed ID: 19399028)

  • 21. Molecular pathways regulating macrophage polarization: implications for atherosclerosis.
    Hoeksema MA; Stöger JL; de Winther MP
    Curr Atheroscler Rep; 2012 Jun; 14(3):254-63. PubMed ID: 22407286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgE Contributes to Atherosclerosis and Obesity by Affecting Macrophage Polarization, Macrophage Protein Network, and Foam Cell Formation.
    Zhang X; Li J; Luo S; Wang M; Huang Q; Deng Z; de Febbo C; Daoui A; Liew PX; Sukhova GK; Metso J; Jauhiainen M; Shi GP; Guo J
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):597-610. PubMed ID: 31996021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atherosclerosis and autoimmunity: a growing relationship.
    Sanjadi M; Rezvanie Sichanie Z; Totonchi H; Karami J; Rezaei R; Aslani S
    Int J Rheum Dis; 2018 May; 21(5):908-921. PubMed ID: 29671956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coinhibitory suppression of T cell activation by CD40 protects against obesity and adipose tissue inflammation in mice.
    Wolf D; Jehle F; Michel NA; Bukosza EN; Rivera J; Chen YC; Hoppe N; Dufner B; Rodriguez AO; Colberg C; Nieto L; Rupprecht B; Wiedemann A; Schulte L; Peikert A; Bassler N; Lozhkin A; Hergeth SP; Stachon P; Hilgendorf I; Willecke F; von Zur Mühlen C; von Elverfeldt D; Binder CJ; Aichele P; Varo N; Febbraio MA; Libby P; Bode C; Peter K; Zirlik A
    Circulation; 2014 Jun; 129(23):2414-25. PubMed ID: 24664276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monocyte fate in atherosclerosis.
    Hilgendorf I; Swirski FK; Robbins CS
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):272-9. PubMed ID: 25538208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting inflammation in cardiovascular diseases. still a neglected field?
    Gómez-Guerrero C; Mallavia B; Egido J
    Cardiovasc Ther; 2012 Aug; 30(4):e189-97. PubMed ID: 21884009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Editorial: update on inflammatory targets modulating atherogenesis.
    Carbone F; Mach F; Montecucco F
    Curr Drug Targets; 2015; 16(4):282-3. PubMed ID: 25859799
    [No Abstract]   [Full Text] [Related]  

  • 28. Atherosclerosis: a classic inflammatory disease.
    Anogeianaki A; Angelucci D; Cianchetti E; D'Alessandro M; Maccauro G; Saggini A; Salini V; Caraffa A; Tete S; Conti F; Tripodi D; Shaik-Dasthagirisaheb YB
    Int J Immunopathol Pharmacol; 2011; 24(4):817-25. PubMed ID: 22230389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy.
    Fredman G; Tabas I
    Am J Pathol; 2017 Jun; 187(6):1211-1221. PubMed ID: 28527709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trained Immunity in Atherosclerotic Cardiovascular Disease.
    Flores-Gomez D; Bekkering S; Netea MG; Riksen NP
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):62-69. PubMed ID: 33147995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treating atherosclerosis with regulatory T cells.
    Foks AC; Lichtman AH; Kuiper J
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):280-7. PubMed ID: 25414253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in therapeutic targeting of inflammation in atherosclerosis.
    Hedin U; Matic LP
    J Vasc Surg; 2019 Mar; 69(3):944-951. PubMed ID: 30591299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mast cells as effectors in atherosclerosis.
    Bot I; Shi GP; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):265-71. PubMed ID: 25104798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles.
    Taleb S; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):258-64. PubMed ID: 25234818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect.
    Fredman G; MacNamara KC
    Cardiovasc Res; 2021 Nov; 117(13):2563-2574. PubMed ID: 34609505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid signaling in adipose tissue: Connecting inflammation & metabolism.
    Masoodi M; Kuda O; Rossmeisl M; Flachs P; Kopecky J
    Biochim Biophys Acta; 2015 Apr; 1851(4):503-18. PubMed ID: 25311170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Major vault protein suppresses obesity and atherosclerosis through inhibiting IKK-NF-κB signaling mediated inflammation.
    Ben J; Jiang B; Wang D; Liu Q; Zhang Y; Qi Y; Tong X; Chen L; Liu X; Zhang Y; Zhu X; Li X; Zhang H; Bai H; Yang Q; Ma J; Wiemer EAC; Xu Y; Chen Q
    Nat Commun; 2019 Apr; 10(1):1801. PubMed ID: 30996248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation.
    Wolfs IM; Donners MM; de Winther MP
    Thromb Haemost; 2011 Nov; 106(5):763-71. PubMed ID: 21947328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atherosclerosis revisited from a clinical perspective: still an inflammatory disease?
    Santovito D; Weber C
    Thromb Haemost; 2017 Jan; 117(2):231-237. PubMed ID: 27975102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abdominal obesity and cardiovascular disease risk: the emerging role of the adipocyte.
    Lee YH; Pratley RE
    J Cardiopulm Rehabil Prev; 2007; 27(1):2-10. PubMed ID: 17474638
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.